O. Kan
Impact in
- Ophthalmology top 5%
- Retinal Diseases and Treatments
- Biotechnology top 10%
- Cancer Research and Treatments
Papers in
-
- Retinal Development and Disorders 4
- CRISPR and Genetic Engineering 4
- RNA Interference and Gene Delivery 2
- PI3K/AKT/mTOR signaling in cancer 2
- Ubiquitin and proteasome pathways 1
- Genetics 5
- Virus-based gene therapy research 5
- Co-authors
- Anthony D. Whetton (7 shared papers)Sharifah Iqball (8 shared papers)Stephen A. Baldwin (3 shared papers)C M Heyworth (3 shared papers)T. M. Dexter (3 shared papers)Susan M. Kingsman (3 shared papers)Simon Naylor (5 shared papers)K. Binley (3 shared papers)
- Journals
- The Journal of Gene Medicine (2 papers)Gene Therapy (2 papers)Human Gene Therapy (2 papers)Biochemical Society Transactions (2 papers)Growth Factors (2 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
O. Kan
19 papers receiving 774 citations
Peers
Comparison fields: 5 of 72
- Ophthalmology 91
- Biotechnology 74
- Immunology 167
- Cancer Research 110
- Genetics 205
Countries citing papers authored by O. Kan
This map shows the geographic impact of O. Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Kan more than expected).
Fields of papers citing papers by O. Kan
This network shows the impact of papers produced by O. Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Kan. The network helps show where O. Kan may publish in the future.
Co-authors
The 25 scholars most cited alongside O. Kan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 179 | |
| 2 | 1990 | 109 | |
| 3 | 1994 | 104 | |
| 4 | 2005 | 79 | |
| 5 | 2005 | 77 | |
| 6 | 2006 | 50 | |
| 7 | 2001 | 42 | |
| 8 | 2009 | 40 | |
| 9 | 2002 | 29 | |
| 10 | 1991 | 21 | |
| 11 | 2007 | 19 | |
| 12 | 1994 | 15 | |
| 13 | 1991 | 14 | |
| 14 | Exploiting the hypoxia response. | 2003 | 10 |
| 15 | 2000 | 5 | |
| 16 | 2008 | 5 | |
| 17 | 1992 | 4 | |
| 18 | 1994 | 4 | |
| 19 | Evaluation of EIAV Based Lentiviral Vectors Following Ocular Delivery in the Nonhuman Primate Model: Development of RetinoStat® | 2008 | 1 |
| 20 | 1999 | 1 |
About O. Kan
O. Kan is a scholar working on Molecular Biology, Genetics, Genetics, Ophthalmology and Immunology, having authored 20 papers that have together received 808 indexed citations. Recurring topics across this work include Virus-based gene therapy research (5 papers), Retinal Development and Disorders (4 papers), CRISPR and Genetic Engineering (4 papers), Retinal Diseases and Treatments (3 papers), RNA Interference and Gene Delivery (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Ophthalmology (91 citations), Biotechnology (74 citations), Immunology (167 citations), Cancer Research (110 citations) and Genetics (205 citations). O. Kan has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Anthony D. Whetton, Sharifah Iqball, Stephen A. Baldwin, C M Heyworth, T. M. Dexter, Susan M. Kingsman, Simon Naylor, K. Binley, Stuart Naylor and Adrian L. Harris. Their work appears in journals such as The Journal of Gene Medicine, Gene Therapy, Human Gene Therapy, Biochemical Society Transactions and Growth Factors.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.